The aim of the present in vivo study was to determine whether a benzodioxan derivative MKC-242, (S)-5-[3-[(1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole hydrochloride, possesses an agonistic activity at postsynaptic serotonin (5-HT) "A receptors in the rat hippocampus when administered systemically. We examined the effects of acute administrations of MKC-242 on the firing activities of dorsal hippocampus CA1 pyramidal neurons. In quiet awake rats, s.c. administrations of MKC-242 significantly decreased the spontaneous firing activity in a dose-dependent manner at doses of 0.3-6 mg\kg. In urethane-anaesthetized rats, i.v. injections of MKC-242, at cumulative doses of 0.3-3 mg\kg, also significantly and dose-dependently inhibited the firing activity induced by microiontophoretically applied quisqualate. These decreasing effects were antagonized by the selective 5-HT "A antagonists WAY-100135 (5 mg\kg, s.c.) and WAY-100635 (0.2 mg\kg, s.c. to the awake rats and 0.4 mg\kg, i.v. to the anaesthetized rats), thereby confirming that MKC-242 decreased the firing activities by stimulating 5-HT "A receptors. The selective depletion of 5-HT produced by the 3-d administration of the 5-HT synthesis inhibitor, parachlorophenylalanine (500 mg\kg;d, i.p.), did not affect the decreasing effect of MKC-242 in the awake animals, indicating that postsynaptic 5-HT "A receptors mediated the decreasing effect. The present results provided the first in vivo electrophysiological evidence that MKC-242, when systemically administered, exerts a 5-HT "A agonistic action at the postsynaptic level.
Introduction
A benzodioxan derivative MKC-242, (S)-5-[3-[(1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole hydrochloride, has a high and selective affinity for serotonin (5-hydroxytryptamine ; 5-HT) "A receptors [K i l 0.35 n against the specific binding of 0.2 n [$H]8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)]. This compound also has a 60-fold lower affinity for α " -adrenoceptors than that for 5-HT "A receptors, and compound in decreasing body temperature, increasing serum corticosterone and inducing the 5-HT syndrome was less than that of 8-OH-DPAT, it has been suggested that MKC-242 is a partial agonist at postsynaptic 5-HT "A receptors (Matsuda et al., 1995b) .
Subsequent behavioural studies using mice and rats have shown that MKC-242 possesses anxiolytic-like and antidepressant-like activities (Abe et al., 1996 ; Matsuda et al., 1995a) . For example, Abe and co-workers (1996) demonstrated that these activities which were assessed by water-lick conflict, social interaction, restraint stress and forced swimming tests, are 100-to 200-fold more potent than those of buspirone and tandospirone. They also observed that co-administration of a 5-HT "A antagonist WAY-100135 (Fletcher et al., 1993) blocked an increase of punished drinking by MKC-242 in the water-lick conflict test, and a decrease of immobility by MKC-242 and 8-OH-DPAT in the forced swimming test, indicating a 5-HT "A receptor mediation (Abe et al., 1996) . Furthermore, it has been shown that co-administration of 1-(2-pyrimidinyl)piperazine (1-PP), an active metabolite of azapirones including buspirone and tandospirone, also attenuated the reduction of immobility produced by MKC-242 and 8-OH-DPAT (Abe et al., 1996) . It has been claimed that 1-PP, an α # -adrenoceptor antagonist, blocks the antidepressant-like effect of buspirone (Cervo et al., 1988 ; Martin, 1991) . Along these lines, Abe et al. (1996) ascribed the potent anxiolytic-and antidepressant-like effects of MKC-242 to its property of not being metabolized to 1-PP. These previously demonstrated pharmacological profiles suggest that MKC-242 is a candidate for a potent anxiolytic and antidepressant drug.
Recently, we have demonstrated that systemic administration of 5-HT "A receptor agonists such as 8-OH-DPAT, buspirone, flesinoxan and ipsapirone suppresses spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons in awake, unrestrained rats. The suppressant effect of buspirone was antagonized by a 5-HT "A antagonist NAN-190 (Claustre et al., 1991) and was unaffected by a selective depletion of endogenous 5-HT in this previous study . Moreover, the rank order of potency of the 5-HT "A agonists in the suppressant effect agreed with the order at postsynaptic 5-HT "A receptors previously determined in behavioural, electrophysiological and biochemical studies (Bockaert et al., 1987 ; Hadrava et al., 1995 ; Kasamo et al., 1994 ; Millan et al., 1992 ; Sprouse and Aghajanian, 1988) . Thus, it has been concluded that systemically administered 5-HT "A agonists suppress the firing activities of CA1 pyramidal neurons by stimulating postsynaptic 5-HT "A receptors in awake rats .
The present study was aimed at electrophysiologically examining whether MKC-242, when systemically administered, acts as a 5-HT "A agonist at a postsynaptic level, in vivo. The following experiments were thus carried out : (1) s.c. administration of MKC-242 to determine the effects on the spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons in awake rats and (2) acute i.v. administration of MKC-242 to determine the effects on the firing activity of the CA1 pyramidal neurons induced by microiontophoretically applied quisqualate in urethane-anaesthetized rats.
This study was presented in part at the 28th Annual Meeting of the Society for Neuroscience (Kasamo et al., 1998) .
Materials and method

Animals
Adult male Wistar rats (Sankyo Laboratories Co. Ltd, Tokyo, Japan), weighing 250-300 g on the day of surgery, or the day of acute experiment, were used. Animals were kept in standard laboratory conditions (12 : 12 light\dark cycle with free access to food and water, at a room temperature of 23p0.5 mC). All experiments were performed in accordance with the National Institute of Health's ' Guide for the Care and Use of Laboratory Animals '.
Recording from CA1 pyramidal neurons and evaluation of drug effects in awake rats
Surgical, recording and data analysing procedures were performed essentially as described in Tada et al. (1999) . The surgery was carried out under pentobarbital anaesthesia (60 mg\kg, i.p. with supplementary injections as necessary). A microelectrode bundle, consisting of two tungsten electrodes (15 µm tip diameter), was permanently attached to a microdrive. The combination of the electrodes and the microdrive was attached to a stereotaxic manipulator and then lowered placing the tips of the electrodes within the cortex above the dorsal hippocampus CA1 region (coordinates : AP, 4.0 mm anterior to lambda ; LM, 2.7 mm lateral to the midline ; V, 1.0 mm ventral to the cortical surface). Four stainless-steel screws were threaded into the skull in bilateral frontal and temporal areas for anchors and the ground. The entire apparatus was anchored to the skull with dental cement.
After a recovery period of at least 7 d, the animals were subjected to the recording and drug administration. The animals were placed in an experimental chamber (40i40i40 cm) where all experimental trials took place. By using the microdrive, the electrodes were advanced in small steps ( 25 µm) until stable unit activities with the characteristics of pyramidal neurons (described below) were encountered. Electrical activities were oscillo-5-HT "A agonistic property of MKC-242 scopically monitored throughout, from the start of the electrode-advancing procedure to the end of data collection. Extracellular unit activities from the microelectrodes (bandpass : 0.3-10 kHz) were stored on magnetic tape using a data recorder (MR 30, TEAC, Tokyo, Japan ; tape speed 38 cm\s). To eliminate cable movement artifacts, an operational amplifier (TL074CN, Texas Instruments, Dallas, TX, USA) was used. The unit activities were then printed out on paper by a thermal recorder (RTA 1200, Nihon Kohden, Tokyo, Japan). The firing frequency was counted by the visual inspection of these tracings. When necessary, isolation of a single neuron from multiple-unit recording was carried out by tracing waveforms onto semi-opaque paper, then distinguishing individual neurons based on both amplitudes and shapes of spikes. The criteria for identifying a complex-spike cell were as follows : (1) The neuron showed a spontaneous burst of 2-9 action potentials of decreasing amplitude and increasing duration, and (2) the negative spike duration was 0.4-0.6 ms. These criteria were generated on the basis of previous studies (Fox and Ranck, 1975 ; Suzuki and Smith, 1985) . All data collection was performed during the latter half of the light segment of the light\dark cycle.
Recordings with low signal-to-noise ratios ( 5 : 1) were not employed for data analysis. When the estimated firing frequency of a neuron was 0.2 Hz and lower, the neuron was excluded from the data to avoid misinterpretation of the drug effects due to under-or overestimation of the firing frequency. If the firing frequency is low, the appearance of one firing event could cause a drastic change in the evaluation. For example, only two events appear on the selected 20-s tracing when the firing frequency is 0.1 Hz. If the other two firing events had occurred several 10 ms before and after the tracing, the evaluation might be 0.2 Hz. Thus, it seems reasonable to exclude neurons of low-firing frequencies in order to minimize such inadequate evaluation. Figure 1A shows typical thermal recorder tracings from a complex-spike cell. In the present experiments using awake animals, the firing frequency refers to the number of the firing events\s rather than the number of spikes\s. Therefore, each of the firing events presented in Figure 1A (1-3) was counted as one event instead of counting them as 1, 2 and 5 spikes, respectively. In previous studies on the firing activity of CA1 cells using awake rats, the firing frequency has referred to the number of events\s. We followed this counting method to see if the obtained firing frequency is comparable to that reported previously (Fox and Ranck, 1975 ; Suzuki and Smith, 1985) .
Recordings obtained over 20-s segments during preand post-drug sessions were subjected to estimates of firing frequencies of individual neurons. The effect of the drug was evaluated by direct comparison of absolute firing frequency between the pre-and post-drug sessions for an individual neuron. In addition, the mean number of spikes\event of an individual neuron for each session was calculated to see whether the drugs could alter the complex-spike firing characteristics of the pyramidal neurons. The post-drug sessions for the equivalent volume of saline (0.5 ml\kg, s.c.), MKC-242 (0.03-6 mg\kg, s.c.), WAY-100135 (5 mg\kg, s.c.) and WAY-100635 (0.2 mg\kg) alone started 10 min after injection and lasted up to 5 min. When the neuronal firing was completely suppressed by MKC-242, we subsequently injected WAY-100635 (0.2 mg\kg, s.c.) to confirm that the decline in the firing reflects a decrease in the firing rate rather than drift of the neuron away from the recording electrode.
To examine the antagonism of WAY-100135 and WAY-100635, MKC-242 was administered 15 min after the injection of each antagonist. Also in this case, the effect of MKC-242 was determined 10 min after its administration. This time delay from the injection to the start of post-drug sessions was determined based on our previous observations . The first observation is that the value of the 10 min point was closest to the baseline among the data-points of 5, 10, 20 and 30 min after the saline injection. The second is that the maximum effect of the other 5HT "A agonist was achieved 10 min after the s.c. administration. Thus, the 10-min interval seems suitable to avoid influences of handling animals on the measurements and to obtain maximum effect of the present drugs. PCPA (500 mg\ kg;d) was injected for 3 successive days. The effect of MKC-242 on the firing activity after the selective depletion of 5-HT was examined on day 4.
In each experiment, the pre-and post-drug data analysed were chosen from the recordings obtained when the rat showed no observable body movement with its eyes open. In addition, we selected the segments so that the position and direction of the body and head of the rat in the experimental chamber were consistent between the pre-and post-drug segments. These conditions were necessary because the firings of hippocampal pyramidal cells are often space-specific and dependent on behavioural states (O'Keefe and Dostrovsky, 1971 ; Suzuki and Smith, 1985) .
The present unit recording technique allowed us to record firing activities from a neuron for more than 3 h. Therefore, we could often examine the responses of the neuron to several different dosages. In such cases, the intervals between injection of MKC-242 were 1 h. During the intervals, the activity was oscilloscopically monitored to confirm the given neuronal activity appears throughout.
At the end of the recording session, rats were deeply anaesthetized with a lethal dose of pentobarbital, and a direct anodal current was passed through the recording electrode (20 µA for 30 s). Then the rat was perfused intracardially with 10 % formalin. The location of the recording site was examined histologically.
Recordings of the quisqualate-induced firing and evaluation of drug effect in urethane-anaesthetized rats
The rats were anaesthetized with urethane (1.25 g\kg, i.p.) and mounted in a stereotaxic apparatus. Supplemental doses (0.3 g\kg, i.p.) were administered to maintain an adequate level of anaesthesia and to prevent any nociceptive reaction to a paw pinch. CA1 pyramidal neurons are not active during anaesthesia ; we induced firing activity with quisqualate to evaluate the effects of systemically administered MKC-242.
Five-barrelled glass micropipettes were pulled in the conventional manner and their tips were broken back by 10-15 µm under microscopic control. The central barrel was filled with a saturated Fast Green solution in 2  NaCl and was used for unit recordings of the CA1 pyramidal neurons. Three of the side barrels contained quisqualate (1.5m in 200 m NaCl, pH 8 ; RBI, Natick, MA, USA). One of these barrels was used to induce firing. A small ejection current of quisqualate (k5 to k1 nA) was used to induce firing (SEZ3104 ; Nihon Kohden, Tokyo, Japan). The other two barrels were not used for firing induction. Small retaining currents (j10 nA) were passed to block natural leak of quisqualate. The fourth side barrel containing a 2  NaCl solution was used for automatic current balancing. The microelectrodes were lowered at 3.5 mm lateral and 4.5 mm anterior to lambda into the CA1 region of the dorsal hippocampus.
When a pyramidal neuron was encountered, the intensity of the ejection current was adjusted to induce spikes at 8-12 Hz (Fox and Ranck, 1975) . After 10 min had elapsed from the start of the activation, a 2-min predrug (baseline) session occurred and then MKC-242 was administered i.v. via a lateral tail vein at five cumulative doses (0.03-3 mg\kg) at 2-min intervals. The effect of the five injections (i.v.) of the equivalent volume of the vehicle (1.4 ml of 5 % glucose in total) was also examined. WAY-100635, a selective 5-HT "A antagonist, was subsequently injected i.v. (0.4 mg\kg) to verify whether the effect of MKC-242 resulted from an activation of 5-HT "A receptors. The effect of MKC-242 was evaluated by comparing the numbers of spikes counted during the last 50 s of each 2-min session to that of the pre-drug session (baseline). The ejection current for quisqualate was kept constant throughout each experiment.
After the experiment, Fast Green was ejected from the recording electrode for 10 min with a current of 20 nA to mark the position of the recording site. Then the rat was perfused intracardially with 10 % formalin. The location of the recording site was examined histologically.
Drugs
All drugs were freshly prepared. MKC-242, WAY-100135 and WAY-100635 were synthesized in Pharmaceuticals Laboratory 1 of Mitsubishi Chemical (Yokohama, Japan). MKC-242 was suspended in 0.5 % carboxymethylcellulose (CMC) for s.c. injection and dissolved in a 5 % glucose solution for i.v. injection. WAY-100135 was suspended in 0.5 % CMC. WAY-100635 was dissolved in 0.9 % NaCl. PCPA (Tokyo Kasei, Tokyo, Japan) was injected i.p. as a fine suspension in a 0.5 % solution of gum arabic with a drug concentration of 100 mg\ml. antagonists. The modification of effectiveness by pretreatment with PCPA was assessed by comparing the dose-response curves for MKC-242 with and without PCPA pre-treatment using a one-factor ANOVA. The difference in the baseline firing frequencies between awake rats with and without PCPA pre-treatment was analysed by use of a one-factor ANOVA. All ANOVA tests were followed by Newman-Keuls tests.
Statistics
Results
In the experiment using unanaesthetized rats without the PCPA pre-treatment, data were obtained from 63 cells in 18 rats. The mean firing rate of the pyramidal neurons during quiet waking was 0.97p0.13 Hz, which was comparable with rates previously reported during such behavioural states (Suzuki and Smith, 1985 ; Tada et al., 1999) .
Effects of MKC-242 on the spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons in awake rats
The firing frequencies before and after the subcutaneous administration of saline were similar (0.81p0.21 vs. 0.84p0.28 Hz, n l 10). MKC-242 (s.c.) suppressed the firing activity in a dose-dependent manner at doses of 0.1-6 mg\kg ( Figures 1B and 2) . However, the responses to 0.03 mg\kg of MKC-242 varied across the neurons (10-544 % of the baselines). Among the 12 neurons, the firing activity increased in 6 neurons, decreased in 5 neurons and did not change in 1 neuron after the administration of 0.03 mg\kg of MKC-242. The PCPA pre-treatment (500 mg\kg;d, i.p. for 3 d) did not produce a significant change in the dose-response curve for MKC-242. The variable responses of the firing activity to 0.03 mg\kg of MKC-242 were not observed after the PCPA pre-treatment (Figure 2 ). The baseline firing frequency after PCPA was significantly higher than that without PCPA [1.80p0.19 (n l 16) vs. 0.97p0.13 Hz (n l 63), p 0.01].
The numbers of spikes\event of the neurons before and after the each dose of MKC-242 were within the range from 1.82p0.09 (6 mg\kg) to 2.04p0.09 (1 mg\kg) and were not significantly different between the baseline and post-drug values. Similarly, after the PCPA treatment, these values before and after the administrations of MKC-242 ranged from 1.90p0.08 (baseline) to 2.14p0.10 (0.3 mg\kg) and were not different between pre-and post-MKC-242 values. The baseline numbers of spikes\ event with and without the PCPA treatment were not significantly different (2.02p0.09 and 1.90p0.08, respectively). 
Interactions of 5-HT 1A antagonists with the suppressant effect of MKC-242 in awake rats
The 5-HT "A antagonist WAY-100135 (5 mg\kg, s.c.) alone did not alter the firing rate (109.5p21.9 % of the baseline, from 0.68p0.19 to 0.59p0.12 Hz, n l 7) and completely abolished the suppressant effect of MKC-242 (3 mg\kg, s.c. ; Figure 3 ). WAY-100635 (0.2 mg\kg, s.c.) alone increased the firing frequency to 171.4p27.3 % of the baseline with a statistical trend, which was not significant (from 1.57p0.31 to 2.22p0.34 Hz, n l 11, p l 0.07). The subsequent administration of MKC-242 (3 mg\kg) decreased the firing frequency to 129.0p25.7 % (1.65p0.29 Hz) of the baseline. This indicated that MKC-242 produced a 25.7 % reduction without a statistical significance in the firing frequency even in the presence of WAY-100635. This extent of the reduction was much smaller than that produced by 3 mg\kg of MKC-242 alone (66.2 % ; Figure 3 ). The numbers of spikes\event were similar across the datapoints for WAY-100635 (between 1.79p0.11 and 1.85p0.14) and for WAY-100135 (between 1.80p0.12 and 2.06p0.23). 
Effects of MKC-242 on quisqualate-induced firing activity in anaesthetized rats
Discussion
The present in vivo electrophysiological studies using unanaesthetized rats showed that a 5-HT "A receptor agonist MKC-242 suppressed the firing activity of dorsal hippocampus CA1 pyramidal neurons (Figures 1 and 2 ). This observation was consistent with our previous results which demonstrated the similar effects of several 5-HT "A agonists such as 8-OH-DPAT, buspirone, flesinoxan and ipsapirone . In this previous study, we concluded that the suppressant effects of these agonists were produced by a 5-HT "A receptor activation since the inhibiting effect of buspirone was blocked by a 5-HT "A antagonist NAN-190 (Claustre et al., 1991) . Since MKC-242 and these 5-HT "A agonists are chemically unrelated, it was likely that MKC-242 suppressed the spontaneous firing activity by activating 5-HT "A receptors. Similarly, the suppressant effect of MKC-242 on the firing activity was completely abolished by the selective 5-HT "A antagonist WAY-100135 (Figure 3 ; Fletcher et al., 1993) . Another 5-HT "A antagonist WAY-100635 also completely reversed the MKC-242-induced decrease in the quisqualate-induced firing (Figure 4 ; Fletcher et al., 1996) . In awake animals, WAY-100635 per se increased the firing activity and MKC-242 (3 mg\kg, s.c.) seemed to produce a small reduction (25.7 %) even after administration of WAY-100635 (Figure 3) . However, the reduction was not statistically significant and was much smaller than that produced by 3 mg\kg of MKC-242 5-HT "A agonistic property of MKC-242 alone (66.2 % ; Figure 2) . Thus, the presumed reduction seems attributable not to the actual effect of MKC-242 but to non-specific changes such as the variance of the frequency of a neuron across the sessions. If the reduction were the effect of MKC-242, the reduction in the presence of WAY-100635 should not be mediated through 5-HT "A and α " adrenergic receptors since WAY-100135 and WAY-100635 share a highly selective antagonism on 5-HT "A receptors with a moderate affinity for α " adrenoceptors (Fletcher et al., 1993 (Fletcher et al., , 1996 . Given the fact that MKC-242 did not decrease the firing activity under WAY-100135, it is conceivable that MKC-242 decreased the firing activity through the mechanism that is not blocked by WAY-100635 but by WAY-100135. However, both of these 5-HT "A antagonists have negligible affinities for the other neurotransmitter systems (Fletcher et al., 1993 (Fletcher et al., , 1996 . Furthermore, no considerable pharmacological property possessed by WAY-100135, though not by WAY-100635, has been documented so far (Fletcher et al., 1993 (Fletcher et al., , 1996 . Thus, it is again unlikely that MKC-242 actually suppressed the firing activity in the presence of WAY-100635.
As mentioned above, WAY-100135 and WAY-100635 have moderate affinities for α " -adrenoceptors (Assie and Koek, 1996 ; Fletcher et al., 1993 ; Foster et al., 1995) . MKC-242 also has a moderate affinity for α " -adrenoceptors, but it is 60 times lower than that for 5-HT "A receptors (Matsuda et al., 1995b) . It is therefore conceivable that the antagonism of WAY-100135 and WAY-100635 is mediated through α " -adrenoceptors, but this is unlikely for MKC-242. In fact, previous in vitro experiments have shown that a high concentration (0.1 m) of MKC-242 was required to block a noradrenaline-induced increase in intracellular Ca# + in rat astrocytes, indicating that this compound is only a weak antagonist for the α " -adrenoceptor (Matsuda et al., 1995b) . Since this evidence effectively rules out the involvement of the α " -adrenoceptor, it appears that MKC-242 most likely inhibited the firing activity by activating 5-HT "A receptors. Systemically administered 5-HT "A agonists activate both pre-and postsynaptic 5-HT "A receptors (Blier et al., 1989 (Blier et al., , 1993 . It has been well documented that the activation of the presynaptic 5-HT "A autoreceptors by their agonists decreases 5-HT release in the forebrain including the hippocampus Sharp et al., 1989) . Indeed, a previous study has shown that systemically administered MKC-242 reduces 5-HT release in the rat hypothalamus (Matsuda et al., 1995b) . Thus, it was reasonable to assume that MKC-242 itself activates postsynaptic 5-HT "A receptors, whereas it would reduce the degree of the endogenous 5-HT-produced activation of postsynaptic 5-HT "A receptors by decreasing the 5-HT release. Therefore, it was important to establish whether the suppressant effect of MKC-242 was mediated through pre-or postsynaptic mechanisms.
Previously, we demonstrated that a 3-d treatment with PCPA (500 mg\kg;d, i.p.) selectively depletes 5-HT in the rat hippocampus to less than 5 % of the control (Kasamo et al., 1994) . In the present experiments, such selective depletion of 5-HT by the PCPA pre-treatment did not modify the effectiveness of MKC-242 (Figure 2 ). This observation indicates that MKC-242, at doses more than 0.1 mg\kg (s.c.), suppresses the firing activity regardless of a degree of the endogenous 5-HT tone. Thus, it was most likely that MKC-242 suppressed the firing activity by stimulating postsynaptic 5-HT "A receptors.
Interestingly, the response of the firing activity to the low dose of MKC-242 (0.03 mg\kg) was variable across neurons in awake rats (Figure 2 ). This variability cannot be entirely explained at present. One possible explanation is the instability of the spontaneous firing rate across preand post-drug sessions. Since a considerable proportion of hippocampal complex-spike cells is responsive to place fields (O'Keefe and Dostrovsky, 1971) , the variability may be due to the place-field-specific firings of individual neurons. In the present study, the place fields for neurons were not completely controlled, but the state of a recorded neuron was substantially kept constant throughout each experiment. Indeed, the firing rates before and after the saline injection were consistent in the present study (0.81p0.21 vs. 0.84p0.28 Hz, n l 10). Similarly in our previous study carried out with the same experimental procedure, we documented the stability of the firing rate before and 10 min after injections of saline [53-149 % (93.96p8 .26 %) of the baselines ; n l 10 ; Tada et al., 1999] . Therefore, the present remarkable variability in the responses to 0.03 mg\kg of MKC-242 seems not to be due to the instability of the firing frequency.
Another explanation was derived from two present observations. Firstly, after the selective depletion of 5-HT with PCPA , the s.c. injection of 0.03 mg\kg of MKC-242 did not change the firing frequency and did not produce such variability (Figure 2) . Second, the responses of the quisqualate-induced firing activity to i.v. injections of 0.03-0.1 mg\kg of MKC-242 were consistent across the neurons (Figure 4) . It has been claimed that the 5-HT tone is lower during sleep than during the awake state (Jacobs, 1985) . These observations indicate that, after the reduction of 5-HT tone produced by PCPA and by the urethane anaesthesia, the low dose of MKC-242 did not affect the firing frequencies and did not produce the variability (Figures 2 and 4) . The lack of variability after the reduction of the 5-HT tone suggests that the variability was mainly caused by endogenous 5-HT rather than MKC-242 per se. It has been documented that s.c. injection of 0.05 mg\kg of MKC-242 decreases the accumulation of 5-HTP to 50 % of the maximal effect by activating somatodendritic 5-HT "A autoreceptors (Matsuda et al., 1995b) . The low dose of MKC-242 might have reduced 5-HT release from nerve terminals by stimulating somatodendritic 5-HT "A autoreceptors to a degree in which endogenous 5-HT could modulate the firing activity. Such a low dose of MKC-242 did not decrease the firing activity in the PCPA-treated rats (Figure 2) , suggesting MKC-242 could not exert a 5-HT "A agonistic action postsynaptically at this dose. It has been demonstrated that the firing activities of CA1 pyramidal neurons respond in various ways to 5-HT. For example, by using rat hippocampal slices, Roychowdhury et al. (1994) have observed that bath applications of 5-HT produce biphasic responses (inhibition followed by excitation) in 68 %, excitatory responses in 17 % and inhibitory responses in 15 % of the 85 CA1 pyramidal neurons that they investigated. Thus, the distributions of several classes of 5-HT receptors might be variable across CA1 pyramidal neurons. In keeping with this contention, it seems likely that a change in the tone of endogenous 5-HT may produce various changes in the firing frequency of CA1 pyramidal neurons. The tonic modulation of the firing activity of CA1 pyramidal neurons by endogenous 5-HT has been suggested in our recent study . Taken together, it was speculated that the variability was attributable to how individual neurons responded to 5-HT, which was modestly reduced by the low dose of MKC-242. However, properties of MKC-242 that have not been revealed should be taken into account since information on the pharmacological profiles of this new compound is still limited. Abe et al. (1996) have documented anxiolytic-like effects of that are 100-200 times more potent than those of buspirone and tandospirone using the water-lick conflict, and social interaction tests. In this previous study, MKC-242 also exhibited antidepressantlike effects in the forced-swimming and restraint-stress tests whereas buspirone and tandospirone did not (Abe et al., 1996) . These observations led us to expect that MKC-242 would exert a robust suppression. However, when compared to the data presented in our previous study, MKC-242 was equipotent to ipsapirone in suppressing the CA1 firing activity of awake rats (Figure 2 ; Tada et al., 1999) . This inconsistency between the previous behavioural and the present electrophysiological studies might be ascribed to the difference in the routes of administration. In fact, Asano et al. (1997) , in ex vivo experiments, have demonstrated that orally administered MKC-242 at a dose of 0.1 mg\kg significantly inhibits specific binding of [$H]8-OH-DPAT in the rat hippocampus whereas buspirone and tandospirone do not at a dose of 30 mg\kg each (p.o.). These investigators have suggested that the lack of inhibition by buspirone and tandospirone is due to the rapid dissociation of these 5-HT "A agonists. Thus, it might be reasonable to speculate that, when orally administered as in a clinical setting, the ability of MKC-242 to bind to 5-HT "A receptors would be superior to that of buspirone and tandospirone.
The anxiolytic-like effect of MKC-242 has been further documented with another animal model of anxiety, the conditioned fear stress-induced freezing behaviour of rats. Inoue et al. (1996) have shown that the attenuating effect of ipsapirone on the freezing behaviour was not modified by the lesioning of 5-HT neurons with p-chloroamphetamine, indicating the postsynaptic mechanism in this anxiolytic effect of ipsapirone. It has been shown that MKC-242 (s.c.) reduces the freezing behaviour at doses of 1 mg\kg and higher (Muraki et al., 1998) . This dose range was similar to that required to suppress the firing activity of CA1 pyramidal neurons (Figure 2 ). In keeping with the above-mentioned evidence for the postsynaptic mechanism in this animal model, such a similarity of the dose ranges for the electrophysiological and the behavioural studies leads to the tentative speculation that the suppressant effect of 5-HT "A agonists on spontaneous and quisqualate-induced firing activities of pyramidal neurons could be somehow relevant to attenuating the freezing behaviour in rats.
In conclusion, the present study further provided the in vivo evidence that systemically administered MKC-242 exerts an agonistic action at postsynaptic 5-HT "A receptors in the rat brain. This compound is therefore an agonist for both pre-and postsynaptic 5-HT "A receptors, in vivo. Local applications of 5-HT "A agonists into the raphe nuclei and postsynaptic area such as the hippocampus and amygdala have shown that the anxiolytic effects of 5-HT "A agonists are mediated by both or either of pre-and postsynaptic 5-HT "A receptors in some anxiety models of rats . Together with the previous biochemical and behavioural studies, the present results strongly suggest that MKC-242 is a candidate for an anxiolytic drug when administered orally as in clinics.
